Mariette, X. & Criswell, L. A. Primary Sjögren’s Syndrome. N. Engl. J. Med. 379, 97 (2018).
Brito-Zerón, P. et al. Sjögren syndrome. Nat. Rev. Dis. Prim. 2, 16047 (2016).
Segal, B. M., Pogatchnik, B., Henn, L., Rudser, K. & Sivils, K. M. Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: a comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res. 65, 1291–1298 (2013).
Mæland, E., Miyamoto, S. T., Hammenfors, D., Valim, V. & Jonsson, M. V. Understanding fatigue in Sjögren’s syndrome: outcome measures, biomarkers and possible interventions. Front. Immunol. 12, 703079 (2021).
Article PubMed PubMed Central Google Scholar
Unger, J. et al. The experiences of functioning and health of patients with primary Sjögren’s syndrome: a multicenter qualitative European study. Front. Med. 8, 770422 (2021).
Beydon, M. et al. Epidemiology of Sjogren syndrome. Nat. Rev. Rheumatol. 20, 158–169 (2024).
McCoy, S. S. et al. National Sjögren’s foundation survey: burden of oral and systemic involvement on quality of life. J. Rheumatol. 48, 1029–1036 (2021).
Tarn, J. et al. Primary Sjögren’s syndrome: longitudinal real-world, observational data on health-related quality of life. J. Intern. Med. 291, 849–855 (2022).
Article PubMed PubMed Central Google Scholar
Baer, A. N. & Hammitt, K. M. Sjogren’s disease, not syndrome. Arthritis Rheumatol. 73, 1347–1348 (2021).
Baldini, C., Bartoloni, E. & Bombardieri, M. Highlights of the 15th International Symposium on Sjogren’s Syndrome. Clin. Exp. Rheumatol. 40, 2201–2210 (2022).
Brito-Zerón, P. et al. Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome. RMD Open. 5, e001064 (2019).
Article PubMed PubMed Central Google Scholar
Vivino, F. B. et al. Sjogren’s syndrome: an update on disease pathogenesis, clinical manifestations and treatment. Clin. Immunol. 203, 81–121 (2019).
Article CAS PubMed Google Scholar
Fasano, S. et al. Pathogenesis of primary Sjögren’s syndrome beyond B lymphocytes. Clin. Exp. Rheumatol. 38, 315–323 (2020).
Fox, R. I., Fox, C. M., Gottenberg, J. E. & Dörner, T. Treatment of Sjögren’s syndrome: current therapy and future directions. Rheumatology 60, 2066–2074 (2021).
Article CAS PubMed Google Scholar
Retamozo, S., Sisó-Almirall, A., Flores-Chávez, A., Ramos-Casals, M. & Brito-Zerón, P. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert. Opin. Pharmacother. 22, 2359–2371 (2021).
Article CAS PubMed Google Scholar
Ridgewell, D., Thalayasingam, N. & Ng, W. F. Sjögren’s syndrome: shedding light on emerging and key drug targets. Expert. Opin. Ther. Targets 26, 869–882 (2022).
Article CAS PubMed Google Scholar
Zhan, Q. et al. Pathogenesis and treatment of Sjogren’s syndrome: review and update. Front. Immunol. 14, 1127417 (2023).
Article CAS PubMed PubMed Central Google Scholar
Fox, R. I., Fox, C. M. & McCoy, S. S. Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials. Expert. Opin. Emerg. Drugs 28, 107–120 (2023).
Bettacchioli, E. et al. Association of combined anti-Ro52/TRIM21 and anti-Ro60/SSA antibodies with increased Sjögren disease severity through interferon pathway activation. Arthritis Rheumatol. 76, 751–762 (2023).
James, J. A. et al. Unique Sjögren’s syndrome patient subsets defined by molecular features. Rheumatology 59, 860–868 (2020).
Article CAS PubMed Google Scholar
Brito-Zerón, P., Retamozo, S. & Ramos-Casals, M. Phenotyping Sjögren’s syndrome: towards a personalised management of the disease. Clin. Exp. Rheumatol. 36, 198–209 (2018).
Tarn, J. R. et al. Symptom-based stratification of patients with primary Sjögren’s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. Lancet Rheumatol. 1, e85–e94 (2019).
Article PubMed PubMed Central Google Scholar
McCoy, S. S. et al. Symptom-based cluster analysis categorizes Sjögren’s disease subtypes: an international cohort study highlighting disease severity and treatment discordance. Arthritis Rheumatol. 74, 1569–1579 (2022).
Article CAS PubMed PubMed Central Google Scholar
Noaiseh, G. & Baer, A. N. Toward better outcomes in Sjögren’s syndrome: the promise of a stratified medicine approach. Best. Pract. Res. Clin. Rheumatol. 34, 101475 (2020).
Devauchelle-Pensec, V. et al. French national diagnostic and care protocol for Sjogren’s disease. Rev. Med. Interne 44, 423–457 (2023).
de Wolff, L., Arends, S., van Nimwegen, J. F. & Bootsma, H. Ten years of the ESSDAI: is it fit for purpose? Clin. Exp. Rheumatol. 38, 283–290 (2020).
Seror, R. et al. Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome. Ann. Rheum. Dis. 81, 979–989 (2022).
Brito-Zerón, P. et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann. Rheum. Dis. 76, 1042–1050 (2017).
Nocturne, G. & Mariette, X. Advances in understanding the pathogenesis of primary Sjögren’s syndrome. Nat. Rev. Rheumatol. 9, 544–556 (2013).
Article CAS PubMed Google Scholar
Thorlacius, G. E., Björk, A. & Wahren-Herlenius, M. Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. Nat. Rev. Rheumatol. 19, 288–306 (2023).
Article CAS PubMed PubMed Central Google Scholar
Verstappen, G. M., Pringle, S., Bootsma, H. & Kroese, F. G. M. Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis. Nat. Rev. Rheumatol. 17, 333–348 (2021).
Article CAS PubMed PubMed Central Google Scholar
Chatzis, L., Vlachoyiannopoulos, P. G., Tzioufas, A. G. & Goules, A. V. New frontiers in precision medicine for Sjogren’s syndrome. Expert. Rev. Clin. Immunol. 17, 127–141 (2021).
Article CAS PubMed Google Scholar
Björk, A., Mofors, J. & Wahren-Herlenius, M. Environmental factors in the pathogenesis of primary Sjögren’s syndrome. J. Intern. Med. 287, 475–492 (2020).
Lessard, C. J. et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat. Genet. 45, 1284–1292 (2013).
留言 (0)